Texas Tech's Abilene campus gets big cancer research grant - Abilene Reporter-News
Abilene will be home to some cutting-edge cancer research, thanks to a $756,644 grant from the Cancer Prevention and Research Institute of Texas. The Texas Tech University Health Sciences Center at Abilene will use the money to conduct research into a rare genetic disorder. Tuberous sclerosis complex causes the development of tumors throughout multiple organs, including the brain, skin, lung, heart and kidneys. |
Related Stories
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.
Recent Stories
TTUHSC Amarillo Awarded $50,000 Grant for Cutting-Edge Cancer Research
TTUHSC in Amarillo has received a $50,000 grant from the Harrington Cancer and Health Foundation to support groundbreaking cancer research led by Hiranmoy Das, Ph.D.
Concert, Art Exhibit Celebrate End of Two-Week Arts Program for Individuals with Aphasia
Families, friends and members of the Lubbock community showed their support for the arts and those with aphasia at a June 12 concert and art exhibit marking the end of a two-week arts camp.
TTUHSC Researchers to Study Gene’s Role in Prostate Cancer Metastasis
With support from a three-year, $1.85 million grant, Srinivas Nandana, Ph.D., and co-investigator Manisha Tripathi, Ph.D., from the Department of Cell Biology and Biochemistry at the TTUHSC School of Medicine will investigate the role of TBX2.